Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Pfenex Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pfenex Inc market cap is $437.28M.
What is the 52-week high for Pfenex Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pfenex Inc 52 week high is $14.00 as of September 28, 2025.
What is the 52-week low for Pfenex Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pfenex Inc 52 week low is $5.26 as of September 28, 2025.
What was Pfenex Inc stock price yesterday?
Pfenex Inc stock price yesterday was $12.75.
What is the PE ratio of Pfenex Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pfenex Inc’s P/E ratio is -54.21.
What is the Price-to-Book ratio of Pfenex Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pfenex Inc P/B ratio is 5.9178.
What is the 50-day moving average of Pfenex Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pfenex Inc 50-day moving average is $11.36.
